Long‐term follow‐up on systemic bevacizumab treatment in recurrent respiratory papillomatosis
G Evers, C Schliemann, A Beule, LH Schmidt… - The …, 2021 - Wiley Online Library
Objectives/Hypothesis Recurrent respiratory papillomatosis (RRP) is a primarily benign
disease affecting the entire respiratory tract. Treatment is challenging and usually involves …
disease affecting the entire respiratory tract. Treatment is challenging and usually involves …
Long‐Term Follow‐Up on Systemic Bevacizumab Treatment in Recurrent Respiratory Papillomatosis.
G Evers, C Schliemann, A Beule, LH Schmidt… - …, 2021 - search.ebscohost.com
Abstract Objectives/Hypothesis: Recurrent respiratory papillomatosis (RRP) is a primarily
benign disease affecting the entire respiratory tract. Treatment is challenging and usually …
benign disease affecting the entire respiratory tract. Treatment is challenging and usually …
Long-Term Follow-Up on Systemic Bevacizumab Treatment in Recurrent Respiratory Papillomatosis
G Evers, C Schliemann, A Beule… - The …, 2021 - pubmed.ncbi.nlm.nih.gov
Objectives/hypothesis Recurrent respiratory papillomatosis (RRP) is a primarily benign
disease affecting the entire respiratory tract. Treatment is challenging and usually involves …
disease affecting the entire respiratory tract. Treatment is challenging and usually involves …
Long-Term Follow-Up on Systemic Bevacizumab Treatment in Recurrent Respiratory Papillomatosis.
G Evers, C Schliemann, A Beule, LH Schmidt… - The …, 2020 - europepmc.org
Methods To describe experience on long-term systemic bevacizumab administration, we
performed the underlying investigation. Clinical, radiological, and bronchoscopy data were …
performed the underlying investigation. Clinical, radiological, and bronchoscopy data were …